Byotrol Plc
("Byotrol" or the "Company")
Results of General Meeting
Byotrol Plc (AIM: BYOT), the specialist infection prevention and control company, announces that at the Company's General Meeting held earlier today all resolutions were duly passed.
In accordance with the passing of Resolution 1, the Capital Reorganisation will become effective at the close of business today.
In accordance with the passing of Resolution 3, cancellation of admission of the Company's ordinary shares to trading on AIM will become effective at 7.00am on 30 April 2024. In accordance with the passing of Resolution 2, the Company will re-register as a private limited company with the name Byotrol Limited which is expected to take place by 21 May 2024.
The voting details with regards the General Meeting resolutions will be detailed on the Company's website, www.byotrol.com
Shareholders are reminded that the last day of dealings in Byotrol Plc ordinary shares on AIM will be 29 April 2024.
With effect from the cancellation of admission of the Company's ordinary shares to trading on AIM, the Company expects to implement a matched bargain facility in order to facilitate future trading in its shares. A further announcement will be made in due course.
Further details of the cancellation and re-registration are set out in the circular dated 28 March 2024 ("the Circular"). A copy of the Circular is available on the Company's website www.byotrol.com
Unless otherwise indicated, defined terms in this announcement shall have the same meaning as described in the Circular.
For further information contact:
| Byotrol Plc | |
| Dr Trevor Francis, Non- Executive Chairman | +44 (0)1925 742 000 |
| David Traynor, Interim Chief Executive Officer Chris Sedwell, Chief Financial Officer
| |
| | |
| Cavendish Capital Markets Limited (Nominated Adviser and Broker) | +44 (0)20 7220 0500 |
| Geoff Nash/George Dollemore - Corporate Finance Nigel Birks/Harriet Ward - ECM | |
| | |
| | |
| Flagstaff Strategic and Investor Communications | +44 (0)20 7129 1474 |
| Tim Thompson/Andrea Seymour/Fergus Mellon
|
|
This announcement is released by Byotrol Plc and, prior to publication, the information contained herein was deemed to constitute inside information under the Market Abuse Regulations (EU) No. 596/2014. Such information is disclosed in accordance with the Company's obligations under Article 17 of MAR.
Notes to editors
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the animal and human healthare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.
Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.
For more information, go to byotrol.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.